Free Trial

PDS Biotechnology (PDSB) Competitors

PDS Biotechnology logo
$3.22
+0.03 (+0.94%)
(As of 03:43 PM ET)

PDSB vs. SELB, INO, VALN, SIGA, AQST, ALT, PRTC, ALEC, XERS, and AVXL

Should you be buying PDS Biotechnology stock or one of its competitors? The main competitors of PDS Biotechnology include Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), Valneva (VALN), SIGA Technologies (SIGA), Aquestive Therapeutics (AQST), Altimmune (ALT), PureTech Health (PRTC), Alector (ALEC), Xeris Biopharma (XERS), and Anavex Life Sciences (AVXL). These companies are all part of the "medical" sector.

PDS Biotechnology vs.

PDS Biotechnology (NASDAQ:PDSB) and Selecta Biosciences (NASDAQ:SELB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

In the previous week, PDS Biotechnology had 1 more articles in the media than Selecta Biosciences. MarketBeat recorded 1 mentions for PDS Biotechnology and 0 mentions for Selecta Biosciences. PDS Biotechnology's average media sentiment score of 0.00 equaled Selecta Biosciences'average media sentiment score.

Company Overall Sentiment
PDS Biotechnology Neutral
Selecta Biosciences Neutral

Selecta Biosciences has higher revenue and earnings than PDS Biotechnology. PDS Biotechnology is trading at a lower price-to-earnings ratio than Selecta Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PDS BiotechnologyN/AN/A-$42.94M-$1.22-2.71
Selecta Biosciences$110.78M0.00$35.38M-$0.22N/A

26.8% of PDS Biotechnology shares are held by institutional investors. Comparatively, 42.0% of Selecta Biosciences shares are held by institutional investors. 9.5% of PDS Biotechnology shares are held by company insiders. Comparatively, 31.2% of Selecta Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

PDS Biotechnology has a net margin of 0.00% compared to Selecta Biosciences' net margin of -72.04%. Selecta Biosciences' return on equity of -44.13% beat PDS Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
PDS BiotechnologyN/A -137.06% -66.12%
Selecta Biosciences -72.04%-44.13%-22.00%

PDS Biotechnology has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Comparatively, Selecta Biosciences has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

PDS Biotechnology presently has a consensus target price of $14.25, suggesting a potential upside of 335.78%. Given PDS Biotechnology's higher probable upside, equities analysts clearly believe PDS Biotechnology is more favorable than Selecta Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PDS Biotechnology
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Selecta Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Selecta Biosciences received 263 more outperform votes than PDS Biotechnology when rated by MarketBeat users. However, 70.10% of users gave PDS Biotechnology an outperform vote while only 55.63% of users gave Selecta Biosciences an outperform vote.

CompanyUnderperformOutperform
PDS BiotechnologyOutperform Votes
68
70.10%
Underperform Votes
29
29.90%
Selecta BiosciencesOutperform Votes
331
55.63%
Underperform Votes
264
44.37%

Summary

PDS Biotechnology and Selecta Biosciences tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDSB vs. The Competition

MetricPDS BiotechnologyPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$121.87M$7.06B$5.30B$8.52B
Dividend YieldN/A7.92%5.06%4.15%
P/E Ratio-2.716.3498.4613.04
Price / SalesN/A390.651,485.5491.33
Price / CashN/A47.4338.8434.18
Price / Book3.945.574.715.08
Net Income-$42.94M$153.29M$117.71M$225.39M
7 Day Performance6.09%-1.38%-0.48%0.10%
1 Month Performance-9.32%15.21%5.86%4.01%
1 Year Performance-20.81%42.41%37.38%32.40%

PDS Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDSB
PDS Biotechnology
0.8407 of 5 stars
$3.22
+0.9%
$14.25
+342.5%
-23.5%$118.56MN/A-2.6420
SELB
Selecta Biosciences
N/AN/AN/AN/A$136.76M$110.78M-4.0164Analyst Forecast
Gap Down
High Trading Volume
INO
Inovio Pharmaceuticals
3.515 of 5 stars
$5.67
+1.3%
$43.80
+672.5%
-89.9%$146.92M$591,858.000.00127
VALN
Valneva
1.5503 of 5 stars
$6.11
+2.9%
$18.50
+202.8%
-50.7%$496.44M$165.52M-11.75700
SIGA
SIGA Technologies
2.829 of 5 stars
$6.95
+2.7%
N/A+41.6%$496.02M$139.92M5.9440Upcoming Earnings
Options Volume
AQST
Aquestive Therapeutics
1.5966 of 5 stars
$5.44
-0.9%
$8.83
+62.4%
+249.7%$495.25M$58.36M-15.54160Upcoming Earnings
News Coverage
ALT
Altimmune
1.8239 of 5 stars
$6.90
+3.1%
$18.80
+172.5%
+179.7%$490.38M$430,000.00-4.2650Upcoming Earnings
PRTC
PureTech Health
2.9108 of 5 stars
$20.39
+2.0%
$45.00
+120.7%
+13.1%$487.93M$3.33M0.00100Gap Up
ALEC
Alector
4.2686 of 5 stars
$5.01
+5.3%
$17.75
+254.3%
-5.4%$482.89M$55.28M-2.78270Upcoming Earnings
XERS
Xeris Biopharma
4.1354 of 5 stars
$3.24
+1.3%
$4.67
+44.0%
+76.0%$482.76M$163.91M-7.53290News Coverage
AVXL
Anavex Life Sciences
3.3941 of 5 stars
$5.57
+6.3%
$40.00
+618.1%
+18.6%$471.46MN/A-11.1440News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:PDSB) was last updated on 11/1/2024 by MarketBeat.com Staff
From Our Partners